RVPH
Reviva Pharmaceuticals Holdings Inc.
$0.31
+$0.04(+15.27%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$18.13M
Volume
18.41M
52W Range
$0.25 - $4.28
Target Price
$7.00
Order:
Income Statement
| Metric | Trend | Chart | 2019 Feb | 2020 Feb | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-152.8K | $724.7K | $2.4M | $10.1M | $28.2M | $39.5M | $30.8M | ||
| Research & Development | -- | -- | $295.1K | $4.9M | $22.9M | $31.4M | $22.9M | ||
| Research Expense | -- | -- | $295.1K | $4.9M | $22.9M | $31.4M | $22.9M | ||
| Selling, General & Administrative | -- | -- | $2.1M | $5.3M | $5.4M | $8.1M | $7.9M | ||
| General & Administrative Expenses | -- | -- | $2.1M | $5.3M | $5.4M | $8.1M | $7.9M | ||
| Salaries & Wages | -- | -- | -- | -- | -- | $3.4M | $1.6M | ||
| Depreciation & Amortization | -- | -- | $591 | -- | -- | -- | -- | ||
| Depreciation & Amortization | -- | -- | $591 | -- | -- | -- | -- | ||
| Other Operating Expenses | $152.8K | $724.7K | -- | -- | $28.2M | $-640.6K | $-768.1K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-152.8K | $-724.7K | $-2.4M | $-10.1M | $-28.2M | $-39.5M | $-30.8M | ||
| EBITDA | $574.1K | $-706.0K | $-2.3M | $-8.5M | $-28.2M | $-39.2M | $-29.9M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | $-1.3M | $1.5M | $2.4K | -- | -- | $18.5K | ||
| Intinc | $729.5K | $1.9M | $105.2K | -- | -- | $398.4K | $361.4K | ||
| Net Non-Operating Interest Income/Expense | $729.5K | $1.3M | $-1.5M | -- | $-182.8K | $398.4K | $361.4K | ||
| Gain on Sale of Securities | $-2.6K | -- | -- | $1.6M | $-194.7K | $-239.2K | $717.6K | ||
| Other Income/Expense | $2.6K | $-18.7K | $-105.2K | $-1.6M | $-194.7K | $104.9K | $-556.7K | ||
| Other Special Charges | -- | -- | $105.2K | $-2.4K | $-194.7K | $134.3K | $-160.9K | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $574.1K | $-706.0K | $-2.3M | $-8.5M | $-28.2M | $-39.2M | $-29.9M | ||
| Pre-Tax Income | $574.1K | $617.9K | $-3.8M | $-8.5M | $-28.2M | $-39.2M | $-29.9M | ||
| INCOME TAX | |||||||||
| Tax Provision | -- | -- | $800 | $6.0K | $20.8K | $16.9K | $19.5K | ||
| NET INCOME | |||||||||
| Net Income | $574.1K | $617.9K | $-3.8M | $-8.5M | $-28.3M | $-39.3M | $-29.9M | ||
| Net Income (Continuing Operations) | $574.1K | $617.9K | $-3.8M | $-8.5M | $-28.3M | $-39.3M | $-29.9M | ||
| Net Income (Discontinued Operations) | $574.1K | $617.9K | $-3.8M | $-8.5M | $-28.3M | $-39.3M | $-29.9M | ||
| Net Income (Common Stockholders) | $574.1K | $617.9K | $-3.8M | $-8.5M | $-28.3M | $-39.3M | $-29.9M | ||
| Normalized Income | -- | -- | -- | $-6.7M | -- | -- | $-29.6M | ||
| TOTALS | |||||||||
| Total Expenses | $-152.8K | $724.7K | $2.4M | $10.1M | $28.2M | $39.5M | $30.8M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $2.0M | $2.6M | $3.1M | -- | $19.5M | $23.8M | $33.1M | ||
| Average Shares Outstanding (Diluted) | $14.4M | $2.6M | $3.1M | -- | $19.5M | $23.8M | $33.1M | ||
| Shares Outstanding | $68.0M | $7.7M | $9.2M | $68.0M | $20.5M | $27.9M | $68.0M | ||
| Basic EPS | -- | $-0.21 | $-1.24 | -- | $-1.25 | $-1.65 | $-0.90 | ||
| Basic EPS (Continuing Operations) | -- | $-0.21 | $-1.24 | -- | $-1.25 | $-1.65 | $-0.90 | ||
| Diluted EPS | $-0.04 | $-0.21 | $-1.24 | -- | $-1.25 | $-1.65 | $-0.90 | ||
| OTHER METRICS | |||||||||
| Accretion On Preferred Stock | $-650.8K | $1.2M | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | $5.0M | -- | -- | -- | -- | -- | ||
| Net Operating Interest Income Expense | $729.5K | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | -- | -- | $2.1M | $5.3M | $5.4M | $8.1M | $7.9M | ||
| Otherunder Preferred Stock Dividend | $-650.8K | $1.2M | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $-650.8K | $1.2M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVPH | $0.31 | +15.3% | 18.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Reviva Pharmaceuticals Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW